Literature DB >> 32197104

Evidence informing the UK's COVID-19 public health response must be transparent.

Nisreen A Alwan1, Raj Bhopal2, Rochelle A Burgess3, Tim Colburn4, Luis E Cuevas5, George Davey Smith6, Matthias Egger6, Sandra Eldridge7, Valentina Gallo8, Mark S Gilthorpe9, Trish Greenhalgh10, Christopher Griffiths7, Paul R Hunter11, Shabbar Jaffar12, Ruth Jepson13, Nicola Low14, Adrian Martineau7, David McCoy15, Miriam Orcutt4, Bharat Pankhania16, Hynek Pikhart17, Allyson Pollock18, Gabriel Scally6, James Smith8, Devi Sridhar13, Stephanie Taylor15, Peter W G Tennant9, Yrene Themistocleous10, Anne Wilson5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32197104      PMCID: PMC7270644          DOI: 10.1016/S0140-6736(20)30667-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
The UK Government asserts that its response to the coronavirus disease 2019 (COVID-19) pandemic is based on evidence and expert modelling. However, different scientists can reach different conclusions based on the same evidence, and small differences in assumptions can lead to large differences in model predictions. Our country's response to COVID-19 is demonstrably different from how most other countries are responding globally, including elsewhere in Europe. As the government has stressed, it is imperative to delay and flatten the epidemic curve to ensure the National Health Service can cope. This is particularly essential for the UK, which only has 2·5 hospital beds per 1000 population, fewer than in Italy (3·2 per 1000), France (6·0), and Germany (8·0). Initial data from Italy have shown that 9–11% of actively infected patients with COVID-19 required intensive care during the first 10 days of March, 2020. It is not clear how the UK's unique response is informed by the experiences of other countries, particularly those that have achieved relative control over the virus as a result of widespread testing, contact tracing, and state-imposed social distancing measures, such as Singapore, Hong Kong, Taiwan, and South Korea. The WHO-China Joint Mission on Coronavirus Disease shows very clearly that only immediate and decisive public health responses worked to prevent or delay hundreds of thousands of cases in China, and WHO has advised that it is vital to tackle the virus at the early stages with social distancing.5 We welcome the UK Government's announcement that the modelling and data considered by its Scientific Advisory Group for Emergencies will be published in the future. However, we request that the government urgently and openly shares the scientific evidence, data, and models it is using to inform current decision making related to COVID-19 public health interventions within the next 72 h and then at regular intervals thereafter. Time is a luxury we simply do not have as we face this critical public health crisis. As we have already seen in other countries, a matter of a few days can prove critical in terms of saving lives and avoiding health system collapse. As the UK was not the first country to face a COVID-19 outbreak, knowledge of the disease and evidence pertaining to effective public health interventions is increasingly available. However, this is only advantageous if we incorporate the best available evidence from observations elsewhere and use the time this affords us to refine a comprehensive response based on input and scrutiny from a broad base of scientific experts. With the UK increasingly becoming an outlier globally in terms of its minimal social distancing population-level interventions, transparency is key to retaining the understanding, cooperation and trust of the scientific and healthcare communities as well as the general public, ultimately leading to a reduction of morbidity and mortality.
  2 in total

1.  How will country-based mitigation measures influence the course of the COVID-19 epidemic?

Authors:  Roy M Anderson; Hans Heesterbeek; Don Klinkenberg; T Déirdre Hollingsworth
Journal:  Lancet       Date:  2020-03-09       Impact factor: 79.321

Review 2.  COVID-19 and Italy: what next?

Authors:  Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Lancet       Date:  2020-03-13       Impact factor: 79.321

  2 in total
  20 in total

1.  Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.

Authors:  Marko Zdravkovic; Joana Berger-Estilita; Bogdan Zdravkovic; David Berger
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

2.  Amplifying the role of knowledge translation platforms in the COVID-19 pandemic response.

Authors:  Fadi El-Jardali; Lama Bou-Karroum; Racha Fadlallah
Journal:  Health Res Policy Syst       Date:  2020-06-03

3.  Principalism in public health decision making in the context of the COVID-19 pandemic.

Authors:  Paulo Ferrinho; Mohsin Sidat; Gisela Leiras; Fernando Passos Cupertino de Barros; Horácio Arruda
Journal:  Int J Health Plann Manage       Date:  2020-07-10

4.  A real-time policy dashboard can aid global transparency in the response to coronavirus disease 2019.

Authors:  Michael G Head
Journal:  Int Health       Date:  2020-09-01       Impact factor: 2.473

5.  COVID19: The need for public health in a time of emergency.

Authors:  Andrew Lee; Joanne Morling
Journal:  Public Health       Date:  2020-04-08       Impact factor: 2.427

Review 6.  The value proposition of the Global Health Security Index.

Authors:  Sanjana J Ravi; Kelsey Lane Warmbrod; Lucia Mullen; Diane Meyer; Elizabeth Cameron; Jessica Bell; Priya Bapat; Michael Paterra; Catherine Machalaba; Indira Nath; Lawrence O Gostin; Wilmot James; Dylan George; Simo Nikkari; Ernesto Gozzer; Oyewale Tomori; Issa Makumbi; Jennifer B Nuzzo
Journal:  BMJ Glob Health       Date:  2020-10

7.  Summary of the COVID-19 epidemic and estimating the effects of emergency responses in China.

Authors:  Junwen Tao; Yue Ma; Caiying Luo; Jiaqi Huang; Tao Zhang; Fei Yin
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

8.  A nursing informatics response to COVID-19: Perspectives from five regions of the world.

Authors:  Suleman Atique; John R Bautista; Lorraine J Block; Jung Jae Lee; Erika Lozada-Perezmitre; Raji Nibber; Siobhan O'Connor; Laura-Maria Peltonen; Charlene Ronquillo; Jude Tayaben; Friederike J S Thilo; Maxim Topaz
Journal:  J Adv Nurs       Date:  2020-07-22       Impact factor: 3.057

9.  COVID-19: extending or relaxing distancing control measures.

Authors:  Tim Colbourn
Journal:  Lancet Public Health       Date:  2020-03-25

10.  Assessing concerns for the economic consequence of the COVID-19 response and mental health problems associated with economic vulnerability and negative economic shock in Italy, Spain, and the United Kingdom.

Authors:  Cristiano Codagnone; Francesco Bogliacino; Camilo Gómez; Rafael Charris; Felipe Montealegre; Giovanni Liva; Francisco Lupiáñez-Villanueva; Frans Folkvord; Giuseppe A Veltri
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.